News for Corcept Therapeutics Stock (CORT)

Corcept: Key Announcements Coming Soon

Seeking Alpha • 10/15/24

5 Stocks With Recent Price Strength Amid October Volatility

Zacks Investment Research • 10/11/24

3 Strong Buy Momentum Stocks as Bull Market Nears 2-Year Mark

Zacks Investment Research • 10/09/24

Here's Why Investors Should Consider Buying Corcept Stock Now

Zacks Investment Research • 10/02/24

Wall Street Analysts Think Corcept (CORT) Could Surge 41.31%: Read This Before Placing a Bet

Zacks Investment Research • 10/01/24

Here's Why Momentum in Corcept (CORT) Should Keep going

Zacks Investment Research • 10/01/24

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast

Benzinga • 09/30/24

3 Small Biotech Stocks With The 'Big Mo' Right Now

Seeking Alpha • 09/19/24

Corcept (CORT) Moves 6.5% Higher: Will This Strength Last?

Zacks Investment Research • 09/19/24

Corcept Therapeutics - Three Dynamic Catalysts To Reaccelerate Growth

Seeking Alpha • 09/15/24

Corcept Shares Rise More Than 45% in Six Months: Here's Why

Zacks Investment Research • 09/03/24

Corcept (CORT) Upgraded to Buy: Here's Why

Zacks Investment Research • 08/27/24

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT)

PRNewsWire • 08/26/24

Wall Street Analysts Believe Corcept (CORT) Could Rally 70.58%: Here's is How to Trade

Zacks Investment Research • 08/16/24

5 Small Drug Stocks to Buy as Innovation Reaches Peak

Zacks Investment Research • 08/16/24

Corcept Therapeutics Incorporated (CORT) Hits Fresh High: Is There Still Room to Run?

Zacks Investment Research • 08/01/24

Can Corcept (CORT) Run Higher on Rising Earnings Estimates?

Zacks Investment Research • 07/31/24

Are You Looking for a Top Momentum Pick? Why Corcept Therapeutics (CORT) is a Great Choice

Zacks Investment Research • 07/31/24

Wall Street Analysts See a 37.6% Upside in Corcept (CORT): Can the Stock Really Move This High?

Zacks Investment Research • 07/31/24

Corcept Therapeutics: Q2 Gains Overshadowed By Generic Competition And Speculative Pipeline

Seeking Alpha • 07/30/24

Corcept (CORT) Q2 Earnings & Revenues Surpass Estimates

Zacks Investment Research • 07/30/24

Corcept Therapeutics Incorporated (CORT) Q2 2024 Earnings Call Transcript

Seeking Alpha • 07/30/24

Corcept Therapeutics (CORT) Q2 Earnings and Revenues Beat Estimates

Zacks Investment Research • 07/29/24

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

GlobeNewsWire • 07/22/24

These small-cap stocks score highest when screened for quality

Market Watch • 07/17/24